Se ha denunciado esta presentación.
Utilizamos tu perfil de LinkedIn y tus datos de actividad para personalizar los anuncios y mostrarte publicidad más relevante. Puedes cambiar tus preferencias de publicidad en cualquier momento.

Niosomes as Drug Carriers

Niosomes as Drug Carriers

Audiolibros relacionados

Gratis con una prueba de 30 días de Scribd

Ver todo
  • Sé el primero en comentar

Niosomes as Drug Carriers

  1. 1. Niosomes as Drug Carriers<br />
  2. 2. What are Niosomes?<br /><ul><li>Niosomes are non-ionic surfactant vesicles. The success achieved with Liposomal systems stimulated the search for other vesicles forming amphiphiles. </li></li></ul><li>What are Niosomes?<br /><ul><li>Non-ionic surfactants were among the first alternative materials studied. A large number of surfactants have been found to self assemble into bilayer vehicles which can be used as drug delivery. </li></li></ul><li>Structure of Niosomes<br />
  3. 3. Advantages of Niosomes<br /><ul><li>Sustained release of active compounds
  4. 4. Protect drugs from degradation
  5. 5. Unique characteristics:
  6. 6. Biocompatible
  7. 7. biodegradable
  8. 8. non-immunogenic</li></li></ul><li>Advantages of Niosomes<br /><ul><li>Can trap both hydrophilic and lipophilic drugs
  9. 9. Have low toxicity due to non-ionic nature.
  10. 10. Can be used for ophthalmic preparations because their bilayer can efficiently penetrate cornea of the eye.</li></li></ul><li>Applications Of Niosomes<br /><ul><li>Antitumor Niosomes
  11. 11. Niosomes and other drugs
  12. 12. Niosomes as vaccine adjuvants</li></li></ul><li>AntitumourNiosomes<br /><ul><li>Niosomes encapsulation of methotrexate and doxorubicin increase drug delivery to tumour and tumoricidal activity.
  13. 13. Unlike non stealth liposomes, 800 nm doxorubicin niosomes possessing a triglycerol or 200nm doxorubicin niosomes possessing a muramic acid surface are not significantly taken up by RES. These triglycerolniosomes accumulate in the tumour. </li></li></ul><li>Anti-tumor Niosomes<br /><ul><li>This may prove advantageous for treatment of hepatic neoplasm. The encapsulation of these polymeric prodrugs within 200nm niosomes provides a depot system within the liver from which the free drug is gradually cleaved off and the liver level of drug is increased over a 24 hour period.
  14. 14. Activity of other anticancer drugs, such as Vincristine, Bleomycin are also improved with niosomes encapsulation.</li></li></ul><li>Niosome Therapies<br />The uptake of Niosomes by the liver and spleen, makes them ideal for targeting disease manifesting in these organs, i.e. Leismaniasis. <br />A number of studies have shown that Niosomal formulations of sodium stibogluconate improves parasite suppression in acting peptide drugs as intramuscular administration.<br />
  15. 15. Niosomes as Vaccine Adjuvants<br /><ul><li>Niosomal antigens are potent stimulators of the cellular and immune response.
  16. 16. The formulation of antigens as a Niosome in a water-in-oil emulsion further increases the activity of antigens.
  17. 17. Enhancement of the immunological response is due to the controlled release property of the emulsion formulation.</li>

    Sé el primero en comentar

    Inicia sesión para ver los comentarios

  • RaeedDabbagh

    May. 1, 2014
  • amiraabdulwahab

    Dec. 23, 2014
  • 9577472978

    Jun. 6, 2015
  • PrajaktaRamnathkar

    Mar. 2, 2018
  • ChhaviGupta53

    Mar. 8, 2018
  • thirupathiJangili

    Jul. 22, 2019
  • AnujaKaldhone1

    Jan. 5, 2020
  • PradeepKumar3457

    Jan. 20, 2020
  • LavanyaVedhavathi

    Mar. 15, 2021

Niosomes as Drug Carriers

Vistas

Total de vistas

6.933

En Slideshare

0

De embebidos

0

Número de embebidos

15

Acciones

Descargas

0

Compartidos

0

Comentarios

0

Me gusta

9

×